These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 8531896)
1. Sumatriptan does not stimulate PRL and GH secretion in acromegaly. Cuttica CM; Sessarego P; Valenti S; Falivene MR; Giusti M; Giordano G Minerva Endocrinol; 1995 Jun; 20(2):141-4. PubMed ID: 8531896 [TBL] [Abstract][Full Text] [Related]
2. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly. Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053 [TBL] [Abstract][Full Text] [Related]
3. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache. Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633 [TBL] [Abstract][Full Text] [Related]
4. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464 [TBL] [Abstract][Full Text] [Related]
5. Influence of age on the GH response to sumatriptan administration in man. Coiro V; Volpi R; Davoli C; Caffarri G; Chiodera P J Neural Transm Gen Sect; 1995; 101(1-3):195-200. PubMed ID: 8695049 [TBL] [Abstract][Full Text] [Related]
6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
7. Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Cleare AJ; Murray RM; Sherwood RA; O'Keane V Psychol Med; 1998 Mar; 28(2):295-300. PubMed ID: 9572087 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339 [TBL] [Abstract][Full Text] [Related]
9. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia]. Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882 [No Abstract] [Full Text] [Related]
10. Sumatriptan-induced growth hormone release in patients with major depression, mania, and normal controls. Yatham LN; Zis AP; Lam RW; Tam E; Shiah IS Neuropsychopharmacology; 1997 Oct; 17(4):258-63. PubMed ID: 9326750 [TBL] [Abstract][Full Text] [Related]
11. Alcoholism abolishes the growth hormone response to sumatriptan administration in man. Coiro V; Vescovi PP Metabolism; 1995 Dec; 44(12):1577-80. PubMed ID: 8786727 [TBL] [Abstract][Full Text] [Related]
12. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154). Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088 [TBL] [Abstract][Full Text] [Related]
13. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery. Franks S; Jacobs HS; Nabarro JD Clin Endocrinol (Oxf); 1976 Jan; 5(1):63-9. PubMed ID: 813917 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly. Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985 [TBL] [Abstract][Full Text] [Related]
15. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients. Pinessi L; Rainero I; Savi L; Valfrè W; Limone P; Calvelli P; Del Rizzo P; Gianotti L; Taliano M; Ghigo E; Arvat E Cephalalgia; 2000 May; 20(4):223-7. PubMed ID: 10999671 [TBL] [Abstract][Full Text] [Related]